Genetic defect may confer resistance to certain viral infections

NIH study could offer clues for developing new antiviral treatments

2014-04-10

(Press-News.org) WHAT: A National Institutes of Health (NIH) study reports that a rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections. Researchers found that HIV and influenza viruses replicate in the cells of people with congenital disorder of glycosylation type IIb (CDG-IIb) at a much lower rate than in healthy donor cells, creating fewer and less infectious viruses. The study, published in The New England Journal of Medicine, was led by Sergio Rosenzweig, M.D., Ph.D., director of the Primary Immune Deficiency (PID) Clinic at the NIH's National Institute of Allergy and Infectious Diseases (NIAID).

In the study, the researchers diagnosed CDG-IIb in two siblings with severe development issues who were referred to the NIAID PID Clinic though the NIH Undiagnosed Diseases Program. CDG-IIb is extremely rare, with only one other case reported. The genetic defect of the disease disrupts glycosylation, or the process of attaching sugars to proteins. As a result, proteins called gamma globulins, which include infection-fighting antibodies, are unstable and persist at low levels in the patients' blood.

Interestingly, some viruses, including HIV and influenza, depend on glycosylation to form protective shields. The researchers showed that these viruses were less able to replicate or create protective shields because of the glycosylation defects in CDG-IIb cells. In comparison, adenovirus, poliovirus and vaccinia virus, which either do not rely on glycosylation or do not form protective shields, replicated normally when added to both CDG-IIb and healthy cells. This study suggests that modulating aspects of host glycosylation may be a strategy to control certain viral infections.

INFORMATION: ARTICLE: MA Sadat, S Moir et al. Glycosylation, hypogammaglobulinemia and resistance to viral infections. NEJM DOI: 10.1056/NEJMoa1302846 (2014).

WHO: Sergio Rosenzweig, M.D., Ph.D., Director of NIAID's Primary Immune Deficiency Clinic and Deputy Chief of the NIH Clinical Center's Immunology Service, is available to discuss the findings.

CONTACT: To schedule interviews, please contact Linda Huynh, (301) 402-1663, linda.huynh@nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIH...Turning Discovery Into Health ®

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Consuming a high-fat diet is associated with increased risk of certain types of BC

2014-04-09

High total and saturated fat intake were associated with greater risk of estrogen receptor- and progesterone receptor-positive (ER+PR+) breast cancer (BC), and human epidermal growth factor 2 receptor-negative (HER2-) disease, according to a new study published April 9 in the Journal of the National Cancer Institute. Published data from epidemiological and case-control studies on the association between high fat intake and BC risk have been conflicting, which may be attributable to difficulties obtaining accurate information on fat intake and because of limited heterogeneity ...

Older people with faster decline in memory/thinking skills may have lower risk of cancer death

2014-04-09

MINNEAPOLIS – Older people who are starting to have memory and thinking problems, but do not yet have dementia may have a lower risk of dying from cancer than people who have no memory and thinking problems, according to a study published in the April 9, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology. "Studies have shown that people with Alzheimer's disease are less likely to develop cancer, but we don't know the reason for that link," said study author Julián Benito-León, MD, PhD, of University Hospital 12 of October in Madrid, ...

Physical activity associated with lower rates of hospital readmission in patients with COPD

2014-04-09

PASADENA, Calif., April 9, 2014 — Patients with chronic obstructive pulmonary disease (COPD) who participated in any level of moderate to vigorous physical activity had a lower risk of hospital readmission within 30 days compared to those who were inactive, according to a study published today in the Annals of the American Thoracic Society. Researchers examined the electronic health records of 6,042 Kaiser Permanente patients in Southern California who were 40 years or older and who were hospitalized with COPD between Jan. 1, 2011 and Dec. 31, 2012. As part of Kaiser ...

Patients over 65 have more complications after colorectal cancer surgery

2014-04-09

Bottom Line: Most colorectal cancer surgeries are performed on patients older than 65 years, and older patients have worse outcomes than younger patients, although the total number of colon cancer operations has decreased in the past decade. Author: Mehraneh D. Jafari, M.D., and colleagues from the University of California, Irvine School of Medicine, Orange. Background: Gastrointestinal cancers are common in the elderly with peak occurrences in the sixth and seventh decades of life. Colorectal cancer (CRC) is a leading cause of death and surgery remains the curative ...

Scientists firm up origin of cold-adapted yeasts that make cold beer

2014-04-09

MADISON, Wis. — As one of the most widely consumed and commercially important beverages on the planet, one would expect the experts to know everything there is to know about lager beer. But it was just a few years ago that scientists identified the South American yeast that, hundreds of years ago, somehow hitched a ride to Bavaria and combined with the domesticated Old World yeast used for millennia to make ale and bread to form the hybrid that makes lager or cold stored beer. The mystery of the cold-adapted yeast that blended with a distant cousin to make the lager-churning ...

Age does not predict success for those in court-based mental health treatment programs

2014-04-09

COLUMBIA, Mo. – Statistics show that the amount of older adults in the criminal justice system has quadrupled in the past 15 years. Many of the adults have histories of mental health problems and are being placed in court-based treatment programs, where government officials and social workers tend to think that they are more likely to experience success compared to their younger counterparts. However, new research by Kelli Canada, assistant professor in the University of Missouri School of Social Work, shows that although mental health court participants older than 50 adhere ...

TGen identifies growth factor receptors that may prompt metastatic spread of lung cancer

2014-04-09

PHOENIX, Ariz. — April 9, 2014 — Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute (TGen). The hepatocyte growth factor receptor (HGFR/MET) and fibroblast growth factor-inducible 14 (FN14) are proteins associated with the potential spread of non-small cell lung cancer (NSCLC), according to the TGen study published online April 8 by the scientific journal Clinical & Experimental Metastasis. NSCLC represents more than 85 ...

Are chromium supplements helpful in lowering blood sugar levels?

2014-04-09

Coral Gables, FL (April 9, 2014) -- Approximately 26 percent of the U.S. population has impaired fasting glucose, which is a predisposition for developing type 2 diabetes, and chromium supplementation has been suggested as a method that may help control and prevent the disease. A new study by a University of Miami (UM) researcher analyses nearly three decades of data on the effect of chromium supplementation on blood sugar and concludes that chromium supplements are not effective at lowering fasting blood sugar in healthy individuals, or diabetics. Chromium is a mineral ...

Emerging research suggests a new paradigm for 'unconventional superconductors'

2014-04-09

An international team of scientists has reported the first experimental observation of the quantum critical point (QCP) in the extensively studied "unconventional superconductor" TiSe2, finding that it does not reside as predicted within the superconducting dome of the phase diagram, but rather at a full GPa higher in pressure. The surprising result, reported in Nature Physics, suggests that the emergence of superconductivity in TiSe2 isn't associated with the melting of a charge density wave (CDW), as prevailing theory holds; in fact the CDW's amplitude decreases under ...

The motion of the medium matters for self-assembling particles, Penn research shows

2014-04-09

By attaching short sequences of single-stranded DNA to nanoscale building blocks, researchers can design structures that can effectively build themselves. The building blocks that are meant to connect have complementary DNA sequences on their surfaces, ensuring only the correct pieces bind together as they jostle into one another while suspended in a test tube. Now, a University of Pennsylvania team has made a discovery with implications for all such self-assembled structures. Earlier work assumed that the liquid medium in which these DNA-coated pieces float ...

LAST 30 PRESS RELEASES:

WPIA: Accelerating DNN warm-up in web browsers by precompiling WebGL programs

First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study